Plasma Soluble Glycoprotein VI: A Biomarker of Bleeding
Thrombosis and haemostasis（2024）
Abstract
David J. Schneider is the named inventor on a patent (Patent No.: 10,502,737) that proposes the use of FcγRIIa for assaying platelet reactivity and treatment selection.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined